Type IV collagen serum and vitreous fluid levels in patients with diabetic retinopathy. 2001

N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
Department of Laboratory Medicine, Gunma University School of Medicine, Maebashi, Japan.

We compared the levels of type IV collagen (IV-C) in vitreous fluid and serum and the levels of glycosylated haemoglobin in 47 patients with proliferative diabetic retinopathy (DR) and 21 patients with non-inflammatory retinopathies. Levels of IV-C were found to be higher in the vitreous fluid in patients with DR than in patients with non-inflammatory retinopathy (53.2 +/- 14.9 microg/l versus 14.7 +/- 4.5 microg/l). Serum levels were likewise higher in patients with DR (349.7 +/- 106.2 microg/l versus 97.7 +/- 13.1 microg/l) as were glycosylated haemoglobin levels (8.3 +/- 0.3% versus 5.2 +/- 0.4%). In addition, levels of type IV collagen in the vitreous fluid were found to be higher in the patients who had been diabetic for > or = 10 years than in patients who had been diabetic for < 10 years (54.8 +/- 15.5 microg/l versus 16.8 +/- 4.6 microg/l). We conclude that accumulation of vitreous fluid IV-C may relate to high levels of glycosylated haemoglobin and long duration of diabetes. This suggests that the concentration of IV-C in vitreous fluid, and possibly also the serum levels of IV-C, reflects the progression of DR. Further investigation is needed to verify this and to investigate whether or not measuring IV-C levels is a useful means to assess therapeutic effects and/or prognosis of diabetic microangiopathy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012164 Retinal Diseases Diseases involving the RETINA. Disease, Retinal,Diseases, Retinal,Retinal Disease
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D005260 Female Females
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
December 2014, Medical science monitor : international medical journal of experimental and clinical research,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
April 2014, Eye (London, England),
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
June 1994, Diabetes research and clinical practice,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
September 2019, Diabetes research and clinical practice,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
January 2015, Clinical ophthalmology (Auckland, N.Z.),
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
January 1998, Journal of cardiovascular pharmacology,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
July 2023, International ophthalmology,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
October 2016, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
March 2016, Genetic testing and molecular biomarkers,
N Kotajima, and T Kanda, and N Yuuki, and T Kimura, and S Kishi, and Y Fukumura, and I Tamura, and I Kobayashi
June 1997, Diabetic medicine : a journal of the British Diabetic Association,
Copied contents to your clipboard!